help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moore, E. E.
Right arrow Articles by Findlay, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moore, E. E.
Right arrow Articles by Findlay, D. M.

Molecular Endocrinology, Vol 9, 959-968, Copyright © 1995 by Endocrine Society

ARTICLES

Functionally different isoforms of the human calcitonin receptor result from alternative splicing of the gene transcript

EE Moore, RE Kuestner, SD Stroop, FJ Grant, SL Matthewes, CL Brady, PM Sexton and DM Findlay
ZymoGenetics, Seattle, Washington 98102, USA.

Two subtypes of the human calcitonin receptor (hCTR) have been described which differ from one another by the presence or absence of a 16-amino acid insert in the first intracellular loop. Both isoforms were stably expressed in baby hamster kidney cells to compare their ligand binding and second messenger coupling. The binding affinity and the on/off rate of binding for salmon CT were identical for the two receptor isoforms. However, the presence of the insert significantly reduced the ability of the receptor to couple to both adenylate cyclase and phospholipase C. Stimulation of a transient calcium response was only observed with the insert-negative receptor. Similarly, the ED50 for the cAMP response is 100-fold higher for the insert-positive form compared with the insert-negative form of the receptor. However, the maximal cAMP response was equivalent for both receptor isoforms. The rate of internalization of the insert-positive form of the receptor is significantly impaired relative to the insert-negative receptor, which suggests that this process may be dependent on the stimulation of a second messenger pathway. Cloning and characterization of the relevant portion of the hCTR gene revealed that these isoforms are generated by alternative splicing. We also discovered a third isoform of the hCTR, which can be generated by alternative splicing at the same position. The presence of a stop codon in this newly described alternative exon would lead to premature termination of the receptor at the C-terminal end of the first transmembrane domain.


This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
G. V. Shah, A. Muralidharan, M. Gokulgandhi, K. Soan, and S. Thomas
Cadherin Switching and Activation of {beta}-Catenin Signaling Underlie Proinvasive Actions of Calcitonin-Calcitonin Receptor Axis in Prostate Cancer
J. Biol. Chem., January 9, 2009; 284(2): 1018 - 1030.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
M. Morfis, N. Tilakaratne, S. G. B. Furness, G. Christopoulos, T. D. Werry, A. Christopoulos, and P. M. Sexton
Receptor Activity-Modifying Proteins Differentially Modulate the G Protein-Coupling Efficiency of Amylin Receptors
Endocrinology, November 1, 2008; 149(11): 5423 - 5431.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
M. Udawela, G. Christopoulos, M. Morfis, A. Christopoulos, S. Ye, N. Tilakaratne, and P. M. Sexton
A Critical Role for the Short Intracellular C Terminus in Receptor Activity-Modifying Protein Function
Mol. Pharmacol., November 1, 2006; 70(5): 1750 - 1760.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
G. Andreotti, B. L. Mendez, P. Amodeo, M. A. C. Morelli, H. Nakamuta, and A. Motta
Structural Determinants of Salmon Calcitonin Bioactivity: THE ROLE OF THE LEU-BASED AMPHIPATHIC {alpha}-HELIX
J. Biol. Chem., August 25, 2006; 281(34): 24193 - 24203.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
M. Udawela, G. Christopoulos, N. Tilakaratne, A. Christopoulos, A. Albiston, and P. M. Sexton
Distinct Receptor Activity-Modifying Protein Domains Differentially Modulate Interaction with Calcitonin Receptors
Mol. Pharmacol., June 1, 2006; 69(6): 1984 - 1989.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Marzia, R. Chiusaroli, L. Neff, N.-Y. Kim, A. H. Chishti, R. Baron, and W. C. Horne
Calpain Is Required for Normal Osteoclast Function and Is Down-regulated by Calcitonin
J. Biol. Chem., April 7, 2006; 281(14): 9745 - 9754.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
V. Pham, M. Dong, J. D. Wade, L. J. Miller, C. J. Morton, H.-l. Ng, M. W. Parker, and P. M. Sexton
Insights into Interactions between the {alpha}-Helical Region of the Salmon Calcitonin Antagonists and the Human Calcitonin Receptor using Photoaffinity Labeling
J. Biol. Chem., August 5, 2005; 280(31): 28610 - 28622.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
T. Seck, M. Pellegrini, A. M. Florea, V. Grignoux, R. Baron, D. F. Mierke, and W. C. Horne
The {Delta}e13 Isoform of the Calcitonin Receptor Forms a Six-Transmembrane Domain Receptor with Dominant-Negative Effects on Receptor Surface Expression and Signaling
Mol. Endocrinol., August 1, 2005; 19(8): 2132 - 2144.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
K. L. Becker, E. S. Nylen, J. C. White, B. Muller, and R. H. Snider Jr.
Procalcitonin and the Calcitonin Gene Family of Peptides in Inflammation, Infection, and Sepsis: A Journey from Calcitonin Back to Its Precursors
J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1512 - 1525.
[Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. Seck, R. Baron, and W. C. Horne
The Alternatively Spliced {Delta}e13 Transcript of the Rabbit Calcitonin Receptor Dimerizes with the C1a Isoform and Inhibits Its Surface Expression
J. Biol. Chem., June 13, 2003; 278(25): 23085 - 23093.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
D. R. Poyner, P. M. Sexton, I. Marshall, D. M. Smith, R. Quirion, W. Born, R. Muff, J. A. Fischer, and S. M. Foord
International Union of Pharmacology. XXXII. The Mammalian Calcitonin Gene-Related Peptides, Adrenomedullin, Amylin, and Calcitonin Receptors
Pharmacol. Rev., June 1, 2002; 54(2): 233 - 246.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. H. Berlot
A Highly Effective Dominant Negative alpha s Construct Containing Mutations That Affect Distinct Functions Inhibits Multiple Gs-coupled Receptor Signaling Pathways
J. Biol. Chem., May 31, 2002; 277(23): 21080 - 21085.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
E. J. Lee, T. J. Kotlar, I. Ciric, M. K. Lee, S. K. Lim, H. C. Lee, K. B. Huh, K. E. Mayo, and J. L. Jameson
Absence of Constitutively Activating Mutations in the GHRH Receptor in GH-Producing Pituitary Tumors
J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3989 - 3995.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
N. Tilakaratne, G. Christopoulos, E. T. Zumpe, S. M. Foord, and P. M. Sexton
Amylin Receptor Phenotypes Derived from Human Calcitonin Receptor/RAMP Coexpression Exhibit Pharmacological Differences Dependent on Receptor Isoform and Host Cell Environment
J. Pharmacol. Exp. Ther., July 1, 2000; 294(1): 61 - 72.
[Abstract] [Full Text]

Home page
 Mol. Endocrinol.Home page
A. Evdokiou, L.-J. Raggatt, G. J. Atkins, and D. M. Findlay
Calcitonin Receptor-Mediated Growth Suppression of HEK-293 Cells Is Accompanied by Induction of p21WAF1/CIP1 and G2/M Arrest
Mol. Endocrinol., October 1, 1999; 13(10): 1738 - 1750.
[Abstract] [Full Text]

Home page
 EndocrinologyHome page
T. L. Miller, P. A. Godfrey, V. I. DeAlmeida, and K. E. Mayo
The Rat Growth Hormone-Releasing Hormone Receptor Gene: Structure, Regulation, and Generation of Receptor Isoforms with Different Signaling Properties
Endocrinology, September 1, 1999; 140(9): 4152 - 4165.
[Abstract] [Full Text]

Home page
 J. Immunol.Home page
J.-C. Marie, A. Wakkach, A.-M. Coudray, E. Chastre, S. Berrih-Aknin, and C. Gespach
Functional Expression of Receptors for Calcitonin Gene-Related Peptide, Calcitonin, and Vasoactive Intestinal Peptide in the Human Thymus and Thymomas from Myasthenia Gravis Patients
J. Immunol., February 15, 1999; 162(4): 2103 - 2112.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
F. Naro, M. Perez, S. Migliaccio, D. L. Galson, P. Orcel, A. Teti, and S. R. Goldring
Phospholipase D- and Protein Kinase C Isoenzyme-Dependent Signal Transduction Pathways Activated by the Calcitonin Receptor
Endocrinology, July 1, 1998; 139(7): 3241 - 3248.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
W.-J. Chen, S. Armour, J. Way, G. Chen, C. Watson, P. Irving, J. Cobb, S. Kadwell, K. Beaumont, T. Rimele, et al.
Expression Cloning and Receptor Pharmacology of Human Calcitonin Receptors from MCF-7 Cells and Their Relationship to Amylin Receptors
Mol. Pharmacol., December 1, 1997; 52(6): 1164 - 1175.
[Abstract] [Full Text]

Home page
 EndocrinologyHome page
K. J. Perry, M. Quiza, D. E. Myers, M. Morfis, G. Christopoulos, and P. M. Sexton
Characterization of Amylin and Calcitonin Receptor Binding in the Mouse {alpha}-Thyroid-Stimulating Hormone Thyrotroph Cell Line
Endocrinology, August 1, 1997; 138(8): 3486 - 3496.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
D. P. Cohen, C. N. Thaw, A. Varma, M. C. Gershengorn, and D. R. Nussenzveig
Human Calcitonin Receptors Exhibit Agonist-Independent (Constitutive) Signaling Activity
Endocrinology, April 1, 1997; 138(4): 1400 - 1405.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
G. Pozvek, J. M. Hilton, M. Quiza, S. Houssami, and P. M. Sexton
Structure/Function Relationships of Calcitonin Analogues as Agonists, Antagonists, or Inverse Agonists in a Constitutively Activated Receptor Cell System
Mol. Pharmacol., April 1, 1997; 51(4): 658 - 665.
[Abstract] [Full Text]

Home page
 EndocrinologyHome page
M. Quiza, M. Dowton, K. J. Perry, and P. M. Sexton
Electrophoretic Mobility and Glycosylation Characteristics of Heterogeneously Expressed Calcitonin Receptors
Endocrinology, February 1, 1997; 138(2): 530 - 539.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Z. Huang, Y. Chen, S. Pratt, T.-H. Chen, T. Bambino, R. A. Nissenson, and D. M. Shoback
The N-terminal Region of the Third Intracellular Loop of the Parathyroid Hormone (PTH)/PTH-related Peptide Receptor Is Critical for Coupling to cAMP and Inositol Phosphate/Ca2+ Signal Transduction Pathways
J. Biol. Chem., December 27, 1996; 271(52): 33382 - 33389.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J.-F. Shyu, D. Inoue, R. Baron, and W. C. Horne
The Deletion of 14Amino Acids in the Seventh Transmembrane Domain of a Naturally Occurring Calcitonin Receptor Isoform Alters Ligand Binding and Selectively Abolishes Coupling to Phospholipase C
J. Biol. Chem., December 6, 1996; 271(49): 31127 - 31134.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
O. Anusaksathien, C. Laplace, X. Li, Y. Ren, L. Peng, S. R. Goldring, and D. L. Galson
Tissue-specific and Ubiquitous Promoters Direct the Expression of Alternatively Spliced Transcripts from the Calcitonin Receptor Gene
J. Biol. Chem., June 15, 2001; 276(25): 22663 - 22674.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1995 by The Endocrine Society